1
|
Yin KJ, Ren JN, Li X, Fan G, Zhao L, Li Z, Zhang LL, Xie DY, Pan SY, Yuan F. Effect and mechanism of high-fat diet on the preference for sweeteners on mice. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE 2021; 101:1844-1853. [PMID: 32901966 DOI: 10.1002/jsfa.10798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 05/31/2020] [Accepted: 09/09/2020] [Indexed: 06/11/2023]
Abstract
BACKGROUND Male Kunming mice were divided into a normal diet group (control group) and a high-fat diet group (HF group) (185 g·kg-1 protein, 600 g·kg-1 fat and 205 g·kg-1 carbohydrate). After 8 weeks' feeding, behavioral indicators and biochemical indicators in serum were determined. The double-bottle preference experiment was used to study the preferences of mice for five sweeteners. The monoamine neurotransmitter content, gene expression related to dopamine (DA), and opioid receptors were also determined. RESULTS The body weight of the mice in the HF group increased significantly (P < 0.05) after 36 days compared with the control group. The feed intake of the HF group increased sharply in the first 12 days, and then it became basically unchanged. The preference of the HF group for all of the five sweeteners was highly significantly lower (P < 0.01) than that of the control group. Depression-related behavior was observed in the HF group mice. The triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDLC) content in the HF group were very much higher (P < 0.01) than those of the control group. The gene expression related to DA and opioid receptor in the HF group was significantly lower than that of the control group, except for preproenkephalin (PENK). CONCLUSIONS In summary, this study suggested that a long-term high-fat diet could result in a decrease in the preference for sweeteners and could result in a state of reward hypofunction in mice. © 2020 Society of Chemical Industry.
Collapse
Affiliation(s)
- Kai-Jing Yin
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Jing-Nan Ren
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Xiao Li
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Gang Fan
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Lei Zhao
- Food and Agriculture Standardization Institute, China National Institute of Standardization, Beijing, China
| | - Zhi Li
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Lu-Lu Zhang
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Ding-Yuan Xie
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Si-Yi Pan
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| | - Fang Yuan
- College of Food Science and Technology, Huazhong Agricultural University, Key Laboratory of Environment Correlative Dietology, Ministry of Education, Wuhan, China
| |
Collapse
|
2
|
Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist? Schizophr Res 2020; 226:95-110. [PMID: 30935700 DOI: 10.1016/j.schres.2019.03.009] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Revised: 03/08/2019] [Accepted: 03/11/2019] [Indexed: 02/07/2023]
Abstract
Due to the limitations of analytical techniques and the complicity of schizophrenia, nowadays it is still a challenge to diagnose and stratify schizophrenia patients accurately. Many attempts have been made to identify and validate available biomarkers for schizophrenia from CSF and/or peripheral blood in clinical studies with consideration to disease stages, antipsychotic effects and even gender differences. However, conflicting results handicap the validation and application of biomarkers for schizophrenia. In view of availability and feasibility, peripheral biomarkers have superior advantages over biomarkers in CNS. Meanwhile, schizophrenia is considered to be a devastating neuropsychiatric disease mainly taking place in CNS featured by widespread defects in multiple metabolic pathways whose dynamic interactions, until recently, have been difficult to difficult to investigate. Evidence for these alterations has been collected piecemeal, limiting the potential to inform our understanding of the interactions among relevant biochemical pathways. Taken these points together, it will be interesting to investigate possible associations of biomarkers between CNS and periphery. Numerous studies have suggested putative correlations within peripheral and CNS systems especially for dopaminergic and glutamatergic metabolic biomarkers. In addition, it has been demonstrated that blood concentrations of BDNF protein can also reflect its changes in the nervous system. In turn, BDNF also interacts with glutamatergic, dopaminergic and serotonergic systems. Therefore, this review will summarize metabolic biomarkers identified both in the CNS (brain tissues and CSF) and peripheral blood. Further, more attentions will be paid to discussing possible physical and functional associations between CNS and periphery, especially with respect to BDNF.
Collapse
|
3
|
Yang R, Zhang MQ, Xue Y, Yang R, Tang MM. Dietary of n-3 polyunsaturated fatty acids influence neurotransmitter systems of rats exposed to unpredictable chronic mild stress. Behav Brain Res 2019; 376:112172. [DOI: 10.1016/j.bbr.2019.112172] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 08/19/2019] [Accepted: 08/21/2019] [Indexed: 12/21/2022]
|
4
|
Taraskina AE, Zabotina AM, Nasyrova RF, Sosin DN, Sosina KA, Ershov EE, Grunina MN, Krupitsky EM. [The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism]. BIOMEDIT︠S︡INSKAI︠A︡ KHIMII︠A︡ 2018; 64:201-207. [PMID: 29723151 DOI: 10.18097/pbmc20186402201] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Schizophrenia is one of the most serious and common mental disorders, which is characterized by high levels of pathogenic heterogeneity as well as neuroimmune abnormalities, which require treatment with antipsychotic drugs. Monoamines are one of the key neurotransmitters which play an important role in neuroimmune interactions of the human organism. We suggest that the quantity of the monoamine receptors on mononuclear cells of the peripheral blood (PBMCs) can be associated with the cytokine profile of patients. With this quantity being a key component of the mental status correction mechanism in antipsychotic therapy. In this study we measured cytokine levels (IL-6, IL-1b and TGF-b) in blood serum, the protein expression status of the serotonin receptor 5HTR2A and the dopamine receptors D1 (DRD1), DRD2, DRD3 in PBMCs of drug-naive, first episode schizophrenia patients before and after the treatment with olanzapine and haloperidol. This study has shown for the first time that the antipsychotic therapy leads to a decrease in protein levels of monoamine receptors in PBMCs associated with the affinity of the drug used. Blood cytokine levels were significantly higher in serum from studied patients as compared with the reference values. The antipsychotic-linked change of the TGF-b production caused by the therapy is probably associated with the reduction of various monoamine receptors. The relationship between the psychopathological status and the protein level of 5THR2A suggests that the amount of 5HTR2A may serve as a potential biomarker for the personalized appointment of the antipsychotic therapy.
Collapse
Affiliation(s)
- A E Taraskina
- Konstantinov Petersburg Nuclear Physics Institute of National Research Centre "Kurchatov Institute", Leningrad district, Gatchina, Russia; Pavlov First Saint Petersburg State Medical University, Saint-Peterburg, Russia; Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia
| | - A M Zabotina
- Konstantinov Petersburg Nuclear Physics Institute of National Research Centre "Kurchatov Institute", Leningrad district, Gatchina, Russia; Pavlov First Saint Petersburg State Medical University, Saint-Peterburg, Russia
| | - R F Nasyrova
- Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia
| | - D N Sosin
- Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia
| | - K A Sosina
- Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia
| | - E E Ershov
- Kashchenko Saint Petersburg Psychiatric Hospital no.1, Saint-Peterburg, Russia
| | - M N Grunina
- Konstantinov Petersburg Nuclear Physics Institute of National Research Centre "Kurchatov Institute", Leningrad district, Gatchina, Russia
| | - E M Krupitsky
- Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia
| |
Collapse
|
5
|
Tang M, Zhang M, Wang L, Li H, Cai H, Dang R, Jiang P, Liu Y, Xue Y, Wu Y. Maternal dietary of n-3 polyunsaturated fatty acids affects the neurogenesis and neurochemical in female rat at weaning. Prostaglandins Leukot Essent Fatty Acids 2018; 128:11-20. [PMID: 29413357 DOI: 10.1016/j.plefa.2017.11.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2017] [Revised: 10/16/2017] [Accepted: 11/08/2017] [Indexed: 12/17/2022]
Abstract
Long-chain polyunsaturated fatty acids (LC-PUFAs) are rapidly accumulated in brain during pre- and neonatal life, which is important for the development and function of central nervous system. Deficiency of biologically important n-3 PUFA docosahexaenoic acid (C22:6n-3, DHA) is associated with impaired visual, attention and cognition, and would precipitate psychiatric symptoms. However, clinical studies of the potential mechanism on the effect of dietary DHA deficiency on neural development remain unclear. In addition, the effects of n-6 PUFAs and n-3 PUFAs ingestion on the dynamic process of the cell proliferation in neurogenesis of offspring were investigated using immunefluorescence. And GC-MS was used to determine the fatty acid content in the liver of offspring. To further investigate the neurochemical influence on maternal PUFAs levels, we assessed the functioning of various neurotransmitter systems including glutamatergic, dopaminergic, norepinephrinergic and serotoninergic systems in the brain of female rats at weaning by HPLC-MS/MS. Lastly, we analyzed the turnover rates and between-metabolite ratios (the ratios between metabolites of monoamine neurotransmitters) to seek potential links between the neurotransmitters and dietary fatty acids compositions. There were significant differences between the deficiency group and the control or supplementary group in liver fatty acids compositions, showing that n-3 PUFAs were largely replaced by n-6 PUFAs. The generation of n-3 PUFAs deficiency rats exhibited abnormal neurogenesis and neurochemical. Altered dopamine or norepinephrine transmission and between-metabolite ratios in brain areas may be a key neuronal mechanism that contributes to the potential detrimental effects of n-3 PUFAs deficiency for mental health.
Collapse
Affiliation(s)
- Mimi Tang
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; School of Pharmaceutical Sciences, Central South University, Changsha, PR China.
| | - Min Zhang
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; School of Pharmaceutical Sciences, Central South University, Changsha, PR China.
| | - Lu Wang
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.
| | - Huande Li
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.
| | - Hualin Cai
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.
| | - Ruili Dang
- Institute of Clinical Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, PR China.
| | - Pei Jiang
- Institute of Clinical Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272000, PR China.
| | - Yiping Liu
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.
| | - Ying Xue
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; School of Pharmaceutical Sciences, Central South University, Changsha, PR China.
| | - Yanqin Wu
- Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; School of Pharmaceutical Sciences, Central South University, Changsha, PR China.
| |
Collapse
|
6
|
Cao B, Sun XY, Zhang CB, Yan JJ, Zhao QQ, Yang SY, Yan LL, Huang NH, Zeng J, Liao JY, Wang JY. Association between B vitamins and schizophrenia: A population-based case-control study. Psychiatry Res 2018; 259:501-505. [PMID: 29154172 DOI: 10.1016/j.psychres.2017.11.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Revised: 10/11/2017] [Accepted: 11/02/2017] [Indexed: 01/05/2023]
Abstract
To explore the association between schizophrenia and six types of B vitamins, including choline, biotin, riboflavin, pyridoxamine, pyridoxine and nicotinamide, based on the hydrophilic interaction liquid chromatography column (HILIC) Liquid Chromatography-Mass Spectrometry (LC-MS) platform. We conducted the case-control study between November 2015 and September 2016 in Weifang, Shandong Province, China. Blood samples from 128 cases of schizophrenia and 101 controls were collected, and B vitamin were measured by LC-MS coupled with HILIC. The HILIC UPLC-MS based analysis of serum B vitamins levels from 128 cases (30 cases with first-episode, 98 cases with relapse) and 101 controls were performed. The results indicated that lower pyridoxine level and schizophrenia was related. (total cases versus controls: β= -0.215, 95% CI: -0.271, -0.125, p < 0.001; first-episode cases versus controls: β = -0.190, 95% CI: -0.277, -0.103, p < 0.001). Higher nicotinamide level was also associated with schizophrenia after adjusting confounders (β = 0.343, 95% CI: 0.022, 0.664, p = 0.036). Other four B vitamins, including biotin, riboflavin, pridoxamine and choline, were showed no statistically difference in cases versus controls, first episode cases versus relapse cases. Two types of B Vitamins, pyridoxine and nicotinamide, show significant association with the schizophrenia.
Collapse
Affiliation(s)
- Bing Cao
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Xiao-Yu Sun
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Chuan-Bo Zhang
- Mental Health Center of Weifang, Shandong 262400, PR China
| | - Jing-Jing Yan
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Qian-Qian Zhao
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Si-Yu Yang
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Lai-Lai Yan
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Ning-Hua Huang
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Jing Zeng
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China
| | - Jie-Ying Liao
- Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361021, PR China.
| | - Jing-Yu Wang
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, PR China.
| |
Collapse
|
7
|
Taraskina AE, Nasyrova RF, Zabotina AM, Sosin DN, Sosina КА, Ershov EE, Grunina MN, Krupitsky EM. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines. BMC Psychiatry 2017; 17:394. [PMID: 29221470 PMCID: PMC5723030 DOI: 10.1186/s12888-017-1562-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2016] [Accepted: 11/30/2017] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Biomarkers are now widely used in many fields of medicine, and the identification of biomarkers that predict antipsychotic efficacy and adverse reactions is a growing area of psychiatric research. Monoamine molecules of the peripheral bloodstream are possible prospective biomarkers based on a growing body of evidence indicating that they may reflect specific changes in neurotransmitters in the brain. The aim of this study was to detect peripheral biogenic amine indicators of patients with acute psychosis and to test the correlations between the biological measures studied and the psychopathological status of the patients. METHODS This research included 60 patients with acute psychosis treated with olanzapine (n = 30) or haloperidol (n = 30). Here, we measured biogenic amine indicators, including mRNA levels of dopamine receptor D4 (DRD4) and the serotonin 2A receptor (5HTR2A), in peripheral blood mononuclear cells (PBMCs) using quantitative real-time polymerase chain reaction and serum dopamine concentrations by enzyme linked immunosorbent assay (ELISA). Psychopathological status was evaluated using psychometric scales. The assessments were conducted prior to and after 14 and 28 days of treatment. RESULTS The administration of haloperidol, but not olanzapine, up-regulated 5HTR2A mRNA in a linear manner, albeit without statistical significance (p = 0.052). Both drugs had non-significant effects on DRD4 mRNA levels. Nevertheless, a positive correlation was found between DRD4 and 5HTR2A mRNA levels over a longitudinal trajectory, suggesting co-expression of the two genes. A significant positive correlation was observed between 5HTR2A mRNA levels and total Positive and Negative Syndrome Scale (PANSS) scores in both groups of patients before treatment. A significant correlation between baseline 5HTR2A mRNA levels and PANSS scores on days 14 and 28 of treatment remained for patients treated with olanzapine only. Moreover, a significant positive correlation was observed between blood serum dopamine levels and scores on extrapyramidal symptom scales in the olanzapine group. CONCLUSIONS The DRD4 and 5HTR2A genes are co-expressed in PBMCs during antipsychotic administration. Despite a correlation between the studied biogenic amine indicators and the psychopathological status of patients, reliable biomarkers of treatment response could not be determined.
Collapse
Affiliation(s)
- A. E. Taraskina
- Department of Addictions, Department of personalized psychiatry and neurology, V.M. Bekhterev National Medical Research Center Psychiatry and Neurology, ul. Bekhterev, d. 3, Saint-Petersburg, 192019 Russia
- Laboratory of Molecular Biology, First Saint Petersburg Pavlov State Medical University, L’va Tolstogo str. 6/8, Saint-Petersburg, 197022 Russia
- Laboratory of Molecular Human Genetics, National Research Centre “Kurchatov Institute”, Petersburg Nuclear Physics Institute named after B.P. Konstantinov, Leningrad district, Orlova Roscha, Leningrad district, Gatchina, 188300 Russia
| | - R. F. Nasyrova
- Department of Addictions, Department of personalized psychiatry and neurology, V.M. Bekhterev National Medical Research Center Psychiatry and Neurology, ul. Bekhterev, d. 3, Saint-Petersburg, 192019 Russia
| | - A. M. Zabotina
- Laboratory of Molecular Biology, First Saint Petersburg Pavlov State Medical University, L’va Tolstogo str. 6/8, Saint-Petersburg, 197022 Russia
- Laboratory of Molecular Human Genetics, National Research Centre “Kurchatov Institute”, Petersburg Nuclear Physics Institute named after B.P. Konstantinov, Leningrad district, Orlova Roscha, Leningrad district, Gatchina, 188300 Russia
| | - D. N. Sosin
- Department of Addictions, Department of personalized psychiatry and neurology, V.M. Bekhterev National Medical Research Center Psychiatry and Neurology, ul. Bekhterev, d. 3, Saint-Petersburg, 192019 Russia
| | - К. А. Sosina
- Department of Addictions, Department of personalized psychiatry and neurology, V.M. Bekhterev National Medical Research Center Psychiatry and Neurology, ul. Bekhterev, d. 3, Saint-Petersburg, 192019 Russia
| | - E. E. Ershov
- Saint Petersburg Psychiatric Hospital no. 1 named after P.P. Kashchenko, Leningrad region, district, s. Nikolskoye, ul. Menkovskaya, d. 10, Gatchina, Russia
| | - M. N. Grunina
- Laboratory of Molecular Human Genetics, National Research Centre “Kurchatov Institute”, Petersburg Nuclear Physics Institute named after B.P. Konstantinov, Leningrad district, Orlova Roscha, Leningrad district, Gatchina, 188300 Russia
| | - E. M. Krupitsky
- Department of Addictions, Department of personalized psychiatry and neurology, V.M. Bekhterev National Medical Research Center Psychiatry and Neurology, ul. Bekhterev, d. 3, Saint-Petersburg, 192019 Russia
- Laboratory of Molecular Biology, First Saint Petersburg Pavlov State Medical University, L’va Tolstogo str. 6/8, Saint-Petersburg, 197022 Russia
| |
Collapse
|
8
|
Zumárraga M, Arrúe A, Basterreche N, Macías I, Catalán A, Madrazo A, Bustamante S, Zamalloa MI, Erkoreka L, Gordo E, Arnaiz A, Olivas O, Arroita A, Marín E, González-Torres MA. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients. Pharmacogenomics 2016; 17:837-51. [DOI: 10.2217/pgs-2016-0022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Aim: We examined the association of COMT haplotypes and plasma metabolites of catecholamines in relation to the clinical response to antipsychotics in schizophrenic and bipolar patients. Patients & methods: We studied 165 patients before and after four weeks of treatment, and 163 healthy controls. We assessed four COMT haplotypes and the plasma concentrations of HVA, DOPAC and MHPG. Results: Bipolar patients: haplotypes are associated with age at onset and clinical evolution. In schizophrenic patients, an haplotype previously associated with increased risk, is related to better response of negative symptoms. Conclusion: Haplotypes would be good indicators of the clinical status and the treatment response in bipolar and schizophrenic patients. Larger studies are required to elucidate the clinical usefulness of these findings.
Collapse
Affiliation(s)
- Mercedes Zumárraga
- Departamento de Investigación Neuroquímica, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Aurora Arrúe
- Departamento de Investigación Neuroquímica, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Nieves Basterreche
- Unidad de Hospitalización de Corta Estancia, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
- Departamento de Psiquiatría y Psicología Médica, Facultad de Medicina, Universidad del País Vasco, Barrio Sarriena s/n, 48940 Leioa, Bizkaia, Spain
| | - Isabel Macías
- Unidad de Salud Laboral, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Ana Catalán
- Servicio de Psiquiatría, Hospital de Basurto, Osakidetza, Avenida de Montevideo 18, 48013 Bilbao, Spain
| | - Arantza Madrazo
- Servicio de Psiquiatría, Hospital de Basurto, Osakidetza, Avenida de Montevideo 18, 48013 Bilbao, Spain
| | - Sonia Bustamante
- Servicio de Psiquiatría, Hospital de Basurto, Osakidetza, Avenida de Montevideo 18, 48013 Bilbao, Spain
| | - María I Zamalloa
- Departamento de Investigación Neuroquímica, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Leire Erkoreka
- Departamento de Psiquiatría y Psicología Médica, Facultad de Medicina, Universidad del País Vasco, Barrio Sarriena s/n, 48940 Leioa, Bizkaia, Spain
- Centro de Salud Mental de Barakaldo, Red de Salud Mental de Bizkaia, Osakidetza, La Felicidad 9, 3. 48901 Barakaldo, Bizkaia, Spain
| | - Estibaliz Gordo
- Unidad de Hospitalización de Corta Estancia, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Ainara Arnaiz
- Unidad de Hospitalización de Corta Estancia, Hospital de Zamudio, Red de Salud Mental de Bizkaia, Osakidetza, Arteaga Auzoa 45, 48170 Zamudio, Bizkaia, Spain
| | - Olga Olivas
- Centro de Salud Mental de Gernika, Red de Salud Mental de Bizkaia, Osakidetza, San Juan 1, 48300 Gernika, Bizkaia, Spain
| | - Ariane Arroita
- Centro de Salud Mental de Barakaldo, Red de Salud Mental de Bizkaia, Osakidetza, La Felicidad 9, 3. 48901 Barakaldo, Bizkaia, Spain
| | - Elena Marín
- Hospital Psiquiátrico de Bermeo, Tonpoi Bidea s/n. 48370, Bermeo, Bizkaia, Spain
| | - Miguel A González-Torres
- Departamento de Psiquiatría y Psicología Médica, Facultad de Medicina, Universidad del País Vasco, Barrio Sarriena s/n, 48940 Leioa, Bizkaia, Spain
- Servicio de Psiquiatría, Hospital de Basurto, Osakidetza, Avenida de Montevideo 18, 48013 Bilbao, Spain
| |
Collapse
|
9
|
Bošković M, Vovk T, Koprivšek J, Plesničar BK, Grabnar I. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol. Nutr Neurosci 2016; 19:156-61. [DOI: 10.1179/1476830514y.0000000139] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Affiliation(s)
- Marija Bošković
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Tomaž Vovk
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Jure Koprivšek
- Department of Psychiatry, University Clinical Centre Maribor, Maribor, Slovenia
| | | | - Iztok Grabnar
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| |
Collapse
|
10
|
Watanabe K, Miura I, Kanno-Nozaki K, Horikoshi S, Mashiko H, Niwa SI, Yabe H. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia. Psychiatry Res 2015; 230:419-23. [PMID: 26416588 DOI: 10.1016/j.psychres.2015.09.030] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2015] [Revised: 09/01/2015] [Accepted: 09/18/2015] [Indexed: 11/19/2022]
Abstract
The five-factor model of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia symptoms is the most common multiple-factor model used in analyses; its use may improve evaluation of symptoms in schizophrenia patients. Plasma monoamine metabolite levels are possible indicators of clinical symptoms or response to antipsychotics in schizophrenia. We investigated the association between five-factor model components and plasma monoamine metabolites levels to explore the model's biological basis. Plasma levels of homovanillic acid (HVA), 3-methoxy-4-hydroxyphenylglycol (MHPG), and 5-hydroxyindoleacetic acid (5-HIAA) were measured using high-performance liquid chromatography in 65 Japanese patients with schizophrenia. Significant negative correlation between plasma 5-HIAA levels and the depression/anxiety component was found. Furthermore, significant positive correlation was found between plasma MHPG levels and the excitement component. Plasma HVA levels were not correlated with any five-factor model component. These results suggest that the five-factor model of the PANSS may have a biological basis, and may be useful for elucidating the psychopathology of schizophrenia. Assessment using the five-factor model may enable understanding of monoaminergic dysfunction, possibly allowing more appropriate medication selection. Further studies of a larger number of first-episode schizophrenia patients are needed to confirm and extend these results.
Collapse
Affiliation(s)
- Kenya Watanabe
- Department of Pharmacy, Fukushima Medical University Hospital, Fukushima, Japan
| | - Itaru Miura
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan.
| | - Keiko Kanno-Nozaki
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan
| | - Sho Horikoshi
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan
| | - Hirobumi Mashiko
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan
| | - Shin-Ichi Niwa
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan; Department of Neuropsychiatry, Fukushima Medical University Aizu Medical Center, Aizuwakamatsu, Fukushima, Japan
| | - Hirooki Yabe
- Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan
| |
Collapse
|
11
|
Zhou W, Zhu B, Liu F, Lyu C, Zhang S, Yan C, Cheng Y, Wei H. A rapid and simple method for the simultaneous determination of four endogenous monoamine neurotransmitters in rat brain using hydrophilic interaction liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 1002:379-86. [DOI: 10.1016/j.jchromb.2015.08.042] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 08/25/2015] [Accepted: 08/27/2015] [Indexed: 12/27/2022]
|
12
|
Möller M, Swanepoel T, Harvey BH. Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development. ACS Chem Neurosci 2015; 6:987-1016. [PMID: 25794269 DOI: 10.1021/cn5003368] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Schizophrenia is a life altering disease with a complex etiology and pathophysiology, and although antipsychotics are valuable in treating the disorder, certain symptoms and/or sufferers remain resistant to treatment. Our poor understanding of the underlying neuropathological mechanisms of schizophrenia hinders the discovery and development of improved pharmacological treatment, so that filling these gaps is of utmost importance for an improved outcome. A vast amount of clinical data has strongly implicated the role of inflammation and oxidative insults in the pathophysiology of schizophrenia. Preclinical studies using animal models are fundamental in our understanding of disease development and pathology as well as the discovery and development of novel treatment options. In particular, social isolation rearing (SIR) and pre- or postnatal inflammation (PPNI) have shown great promise in mimicking the biobehavioral manifestations of schizophrenia. Furthermore, the "dual-hit" hypothesis of schizophrenia states that a first adverse event such as genetic predisposition or a prenatal insult renders an individual susceptible to develop the disease, while a second insult (e.g., postnatal inflammation, environmental adversity, or drug abuse) may be necessary to precipitate the full-blown syndrome. Animal models that emphasize the "dual-hit" hypothesis therefore provide valuable insight into understanding disease progression. In this Review, we will discuss SIR, PPNI, as well as possible "dual-hit" animal models within the context of the redox-immune-inflammatory hypothesis of schizophrenia, correlating such changes with the recognized monoamine and behavioral alterations of schizophrenia. Finally, based on these models, we will review new therapeutic options, especially those targeting immune-inflammatory and redox pathways.
Collapse
Affiliation(s)
- M. Möller
- Department of Pharmacology and ‡Center of Excellence for Pharmaceutical Sciences,
School of Pharmacy, North-West University, Potchefstroom 2531, South Africa
| | - T. Swanepoel
- Department of Pharmacology and ‡Center of Excellence for Pharmaceutical Sciences,
School of Pharmacy, North-West University, Potchefstroom 2531, South Africa
| | - B. H. Harvey
- Department of Pharmacology and ‡Center of Excellence for Pharmaceutical Sciences,
School of Pharmacy, North-West University, Potchefstroom 2531, South Africa
| |
Collapse
|
13
|
Kotb El-Sayed MI, Amin HK. Catha edulis chewing effects on treatment of paranoid schizophrenic patients. Neuropsychiatr Dis Treat 2015; 11:1067-76. [PMID: 25926735 PMCID: PMC4403690 DOI: 10.2147/ndt.s81011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND The current study's aim is to evaluate the possible interaction effects of khat chewing on treatment of paranoid schizophrenic patients. PATIENTS AND METHODS In the study group, 42 male subjects suffered from paranoid schizophrenia and were classified according to their khat chewing habits into two subgroups: either khat-chewer subgroup (SKc; n=21; r=11, h=10) or non-khat-chewer subgroup (SNKc; n=21, r=11, h=10). Each subgroup was further subdivided according to type of treatment into r (risperidone) and h (haloperidol). Healthy male subjects (37) were subdivided into healthy khat-chewer as positive controls (HKc, n=17) and healthy non-khat-chewer as negative controls (HNKc, n=20). Plasma dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid, 5-hydroxytryptamine (serotonin), 5-hydroxyindoleacetic acid, epinephrine, and norepinephrine were estimated. RESULTS ANOVA and post hoc analysis showed that dopamine was illustrating significant elevation in all khat chewing groups. DOPAC was illustrating significant decrease in all khat chewing groups with an interesting outcome showing significant increase in DOPAC in SNKcr group due to risperidone effect. Homovanillic acid, serotonin, hydroxyindoleacetic acid, and norepinephrine were illustrating significant elevations in all khat chewing groups. Epinephrine was illustrating significant elevation in all chewers than non-chewers groups. Unexpected significant decrease in epinephrine in the SNKcr group indicated that risperidone drug is decreasing epinephrine through indirect mechanism involving calcium. CONCLUSION Khat chewing in schizophrenic patients is contraindicated because it aggravates the disease symptoms, attenuates all used treatment medications, and deteriorates all biochemical markers of the patients.
Collapse
Affiliation(s)
- Mohamed-I Kotb El-Sayed
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Ain Helwan, Helwan, Cairo, Egypt
| | - Hatem-K Amin
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Ain Helwan, Helwan, Cairo, Egypt
| |
Collapse
|
14
|
A lack of positive effect of enhanced vegetative nervous system tonus on mobilization of hematopoietic stem and progenitor cells in patients suffering from acute psychotic syndromes. Leukemia 2012. [PMID: 23207520 DOI: 10.1038/leu.2012.349] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
15
|
Association of SOD2, GPX1, CAT, and TNF Genetic Polymorphisms with Oxidative Stress, Neurochemistry, Psychopathology, and Extrapyramidal Symptoms in Schizophrenia. Neurochem Res 2012; 38:433-42. [DOI: 10.1007/s11064-012-0937-4] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2012] [Revised: 11/17/2012] [Accepted: 11/20/2012] [Indexed: 11/25/2022]
|
16
|
Zheng X, Kang A, Dai C, Liang Y, Xie T, Xie L, Peng Y, Wang G, Hao H. Quantitative Analysis of Neurochemical Panel in Rat Brain and Plasma by Liquid Chromatography–Tandem Mass Spectrometry. Anal Chem 2012; 84:10044-51. [DOI: 10.1021/ac3025202] [Citation(s) in RCA: 78] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Xiao Zheng
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - An Kang
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Chen Dai
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Yan Liang
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Tong Xie
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Lin Xie
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Yin Peng
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Guangji Wang
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| | - Haiping Hao
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
| |
Collapse
|
17
|
Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS. Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone. J Proteome Res 2012; 11:4338-50. [PMID: 22800120 DOI: 10.1021/pr300459d] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Early findings propose that impaired neurotransmission in the brain plays a key role in the pathophysiology of schizophrenia. Recent advances in understanding its multiple etiologies and pathogenetic mechanisms provide more speculative hypotheses focused on even broader somatic systems. Using a targeted tandem mass spectrometry (MS/MS)-based metabolomic platform, we compared metabolic signatures consisting of monoamine and amino acid neurotransmitter (NT) metabolites in plasma/urine simultaneously between first-episode neuroleptic-naïve schizophrenia patients (FENNS) and healthy controls before and after a 6-week risperidone monotherapy, which suggest that the patient NT profiles are restoring during treatment. To detect and identify potential biomarkers associated with schizophrenia and risperidone treatment, we also performed a combined ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) and 1H nuclear magnetic resonance (NMR)-based metabolomic profiling of the same samples, indicating a further deviation of the patients' global metabolic profile from that of controls. The NTs and their metabolites together with the 32 identified biomarkers underpin that metabolic pathways including NT metabolism, amino acid metabolism, glucose metabolism, lipid metabolism, energy metabolism, antioxidant defense system, bowel microflora and endocrine system are disturbed in FENNS. Among them, pregnanediol, citrate and α-ketoglutarate (α-KG) were significantly associated with symptomatology of schizophrenia after Bonferroni correction and may be useful biomarkers for monitoring therapeutic efficacy. These findings promise to yield valuable insights into the pathophysiology of schizophrenia and may advance the approach to treatment, diagnosis and disease prevention of schizophrenia and related syndromes.
Collapse
Affiliation(s)
- Hua-Lin Cai
- Clinical Pharmacy and Pharmacology Research Institute, the Second Xiangya Hospital of Central South University, and School of Pharmaceutical Sciences, Central South University, Changsha, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|